Pueraria Mirifica Results Timeline: What to Expect
What published research actually shows about Pueraria Mirifica results, month by month.
How estrogen, progesterone and other hormones shape the breasts through puberty, pregnancy and menopause, and what HRT and phytoestrogens do.
Estrogen is the main hormone driving breast growth, working with progesterone, growth hormone, insulin and prolactin. Estrogen builds the duct system during puberty, and progesterone builds the milk-making glands. Hormone therapy can change the breasts too, but it is a prescribed medical treatment, not a way to increase size, so ask a doctor.
Breast growth is a team effort. Estrogen is the most influential hormone in puberty, stimulating growth of the glandular duct system, while progesterone is linked to alveolar growth, according to a medical textbook chapter on adolescent development. Growth hormone, insulin, prolactin, thyroxine and cortisol also matter. The same chapter notes that estrogen needs insulin to stimulate epithelial growth and growth hormone to drive duct growth.
In pregnancy, estrogen, progesterone and prolactin carry on the work. A 2024 review of mammary gland changes across life reports that the largest growth of the breast gland occurs up to the 22nd week of pregnancy, and that after birth, falling estrogen and progesterone allow prolactin to be released.
Hormones are only part of the story. Size also depends on genes and body fat. In its guidance on feminizing hormone therapy, UCSF notes that higher estrogen levels in non-transgender women are not necessarily associated with larger breasts. For more on how hormone levels relate to size, see The Relationship Between Breast Size and Hormone Levels, and for changes in sensitivity, see How Hormones Affect Breast Size and Sensitivity.
The table below shows how the main hormones act at each stage. Each row links to its source.
| Hormone | Life stage | Effect on the breast | Source |
|---|---|---|---|
| Estrogen | Puberty | Stimulates growth of the milk-duct system. Fat also begins to collect in the connective tissue, which is the first visible sign. | Medical textbook chapter | Johns Hopkins Medicine |
| Progesterone | Second half of each cycle, and pregnancy | Linked to growth of the glandular buds that can later make milk. | Johns Hopkins Medicine |
| Growth hormone and insulin | Puberty | Needed alongside estrogen for duct and epithelial growth. | Medical textbook chapter |
| Prolactin | Pregnancy and after birth | Supports gland development, and triggers milk release once estrogen and progesterone fall after birth. | 2024 review in PMC | EBSCO health summary |
| Estrogen and progesterone swings | Menstrual cycle | Cyclical tenderness and small changes in size. | EBSCO health summary |
| Falling estrogen | Menopause | The final stage of breast development is regression of the ducts. | Medical textbook chapter |
| Menopausal hormone therapy | After menopause | Breast fullness, tenderness and higher density are among the common effects in some women. | Journal of Women’s Health, 2022 |
A few details behind the table. At puberty, when the ovaries start to make estrogen, fat in the connective tissue begins to collect, and in the second half of each cycle progesterone takes over, according to Johns Hopkins Medicine. The menstrual cycle brings cyclical tenderness and small changes in size, and within three to four days after birth estrogen and progesterone fall rapidly so that prolactin can start milk production, per an EBSCO health summary. After menopause, the final life stage described in the textbook chapter is regression of the ducts.
Not as a goal. In menopausal hormone therapy, breast changes are side effects, and they vary from woman to woman. A 2022 review in the Journal of Women’s Health lists breast fullness, increased breast density and increased breast cancer risk among the common adverse effects. It adds that the density increase is most prominent in the first year and that it returns to baseline after stopping. Another review in PMC reports an association between hormone therapy, particularly combined estrogen and progestin, and a small increased risk of breast cancer, plus breast pain or tenderness.
For transgender women on prescribed feminizing hormone therapy, breast development is an expected effect. A 2023 review in Neurourology and Urodynamics describes breast growth with a maximum time course of 2 to 5 years, and notes the time course is largely based on clinical observation. UCSF adds that response is individualized, with breast growth variable in both degree and timing. This is a monitored medical treatment with bloodwork and dose adjustments by a prescriber, not something to self-direct.
Whether hormone therapy is right for you is a conversation for your doctor, who can weigh your symptoms, health history and risks. For how herbal options compare with HRT on safety, see Pueraria Mirifica vs HRT: Safety Research.
Partly, and much more weakly. A 2026 CDC report on bioactive phytoestrogens says isoflavones and lignans act as weak ligands for estrogen receptors, with a preference for estrogen receptor beta, and are generally much less potent than the body’s own estrogens. An overview of phytoestrogens adds that their activity can be estrogen-like in some tissues and anti-estrogen-like in others, similar to selective estrogen receptor modulators.
Pueraria mirifica is a Thai plant whose phytoestrogens include miroestrol; see What Is Miroestrol? for the compound itself. In a rat study, it exerted estrogenic effects in the mammary gland and uterus, which is an animal result only. In people, a 24-week trial in 71 postmenopausal women reported a change in a bone turnover marker and no estrogen-like effect on the womb lining.
None of this means a phytoestrogen works like prescribed hormones, or that it changes breast size. We found no published human trial showing that Pueraria mirifica does, and a clinical overview on Drugs.com says no literature supports breast enlargement use.
Most breast changes are harmless, but some should be checked. Mayo Clinic advises seeing a doctor if a lump is new and feels firm or fixed, if a lump does not go away after 4 to 6 weeks, if you notice skin changes such as dimpling or puckering, if fluid comes out of the nipple suddenly on more than one occasion, if the nipple has recently turned inward, or if there is a new lump in the armpit.
Cancer Research UK lists a new lump or thickening, skin changes such as puckering, dimpling, a rash or redness, and changes in nipple position as reasons to see a GP. Pain on its own is not usually a sign of cancer, according to Breast Cancer Now, but any new or unusual change is worth getting checked.
If you are on hormone therapy and breast tenderness does not settle, or a change worries you, tell your prescriber. They can review your treatment, and no one should adjust or stop prescribed hormones on their own.
No single hormone. Estrogen is the most influential during puberty, progesterone is linked to gland growth, and growth hormone, insulin and prolactin also play roles, according to a medical textbook chapter. Size also depends on genes and body fat. This describes how the body works. It is not advice to take hormones.
In puberty, estrogen is the main driver of breast growth, per Johns Hopkins Medicine. Later in life, extra estrogen from hormone therapy can cause fullness and higher breast density in some women, and a 2022 review notes that density changes can return to baseline after stopping.
Breast fullness and tenderness are common effects of menopausal hormone therapy, as described in the 2022 review, but they are side effects, not a goal of treatment. Whether HRT suits you is a decision for you and your doctor.
We found no published human trial showing that Pueraria mirifica does, and a clinical overview on Drugs.com says no literature supports breast enlargement use. We do not recommend any herb or hormone for this purpose.
Shifting estrogen and progesterone levels cause cyclical tenderness and small changes in size, according to an EBSCO health summary.
See a doctor for a new lump, skin dimpling, a nipple that turns inward, nipple fluid, or a new change in size or shape, as listed by Mayo Clinic. Most breast changes are not cancer, but they should be checked.
Explore Stherb’s Thai herbal skincare and supplements, crafted from research-backed botanicals.